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Aims To prospectively compare cardiac magnetic resonance late gadolinium enhancement (LGE) findings created by standard
vs. robotically assisted catheter ablation lesions and correlate these with clinical outcomes.
Methods
and results
Forty paroxysmal atrial fibrillation patients (mean age 54+ 13.8 years) undergoing first left atrial ablation were rando-
mized to either robotic-assisted navigation (Hansen Senseiw X) or standard navigation. Pre-procedural, acute (24 h
post-procedure) and late (beyond 3 months) scans were performed with LGE and T2W imaging sequences and percent-
age circumferential enhancement around the pulmonary vein (PV) antra were quantified. Baseline pre-procedural
enhancements were similar in both groups. On acute imaging, mean % encirclements by LGE and T2W signal were
72% and 80% in the robotic group vs. 60% (P ¼ 0.002) and 76%(P ¼ 0.45) for standard ablation. On late imaging, the
T2W signal resolved to baseline in both groups. Late gadolinium enhancement remained the predominant signal with
56% encirclement in the robotic group vs. 45% in the standard group (P ¼ 0.04). At 6 months follow-up, arrhythmia-
free patients had an almost similar mean LGE encirclement (robotic 64%, standard 60%, P ¼ 0.45) but in recurrences,
LGE was higher in the robotic group (43% vs. 30%, P ¼ 0.001). At mean 3 years follow-up, 1.3 procedures were per-
formed in the robotic group compared with 1.9 (P, 0.001) in the standard to achieve a success rate of 80% vs. 75%.
Conclusion Robotically assisted ablation results in greater LGE around the PV antrum. Effective lesions created through improved
catheter stability and contact force during initial treatment may have a role in reducing subsequent re-do procedures.
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Introduction
Arrhythmia recurrences following pulmonary vein isolation (PVI)
in paroxysmal atrial fibrillation (PAF) are almost universally asso-
ciated with electrical reconnection between the left atrium (LA)
and pulmonary veins (PVs).1 Acute PV electrical isolation achieved
following energy delivery to the left atrial-pulmonary vein (LA-PV)
junction or antrum2 does not always translate into long-term clinical
success, with only 50–60% of patients being cured following a single
procedure.3,4 The formation of a durable permanent transmural scar
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is critical to block electrical conduction between the LA and PVs and
to prevent spontaneous PV ectopics from triggering AF.
Over the last 5 years, studies have confirmed that radiofrequency
(RF) lesions within the LA can be visualized using late gadolinium en-
hancement (LGE) cardiac magnetic resonance (CMR) imaging.5– 9
A good correlation between greater amounts of LGE quantified fol-
lowing ablation and a successful clinical outcome has been demon-
strated.7 In the acute setting, T2-weighted imaging enables edema
visualization while LGE imaging is likely to represent both necrotic
and inflamed tissue.10 In the chronic scans, it is possible that areas
of non-necrotic tissue may either recover or progress to form a
scar; the latter case is distinguished by LGE imaging. The more com-
plete the encirclementby tissuenecrosis around thePV, the less likely
that LA to PV conduction will be restored.
It has been shown that RF lesion depth and dimensions are heavily
influenced by contact force,11 catheter tip orientation and catheter
stability.12 The use of steerable introducers, high-frequency jet ven-
tilation, and robotic assistance has been shown to improve catheter
stability. The Hansen-Robotic-System has an incorporated pressure
sensing mechanism (IntelliSense) to determine the force exerted and
the ability to maintain a stable catheter tip position.13 To date, the
correlations between catheter stability, improved delivery of RF
energy and enhanced occurrence of irreversible tissue injury have
been assessed by clinical outcomes and freedom from arrhythmia.
This mechanistic study is the first to examine the role of catheter
stability during the index PVI procedure and correlate this with tissue
injury via CMR late gadolinium findings.
Methods
Patient population
Forty patients (28 male, mean age 54+ 13.8 years) with symptomatic,
drug refractory PAF undergoing their first PVI were randomly assigned
to robotically assisted vs. standard wide area circumferential ablation.
Randomization was performed based on the procedural admission day.
Robotic-assisted catheter ablation was performed on all PAF patients ad-
mitted on the second dayof the week while patients attending on the first
day and fourth day of the week underwent a standard catheter ablation.
All scans used for the purposes of data analysis were deemed of adequate
quality for analysis by an experienced CMR operator. Therapeutic
anti-coagulation with an INR .2 for at least 4 weeks prior to the pro-
cedure was mandated. The study was approved by the local research
ethics committee.
Acute procedural success wasdefined as isolation of all PVs, confirmed
using a circumferential mapping catheter. Patients were followed in clinic
to assess symptoms. Twenty-four hour Holter monitors were per-
formed at 6 months from the index procedure. Every effort was made
to obtain electrocardiogram (ECG) recordings of symptomatic recur-
rences. Recurrences were defined on the basis of (i) symptoms with
ECG evidence of the presence of any sustained atrial arrhythmia or
(ii) the presence of symptomatic or asymptomatic episodes of atrial ar-
rhythmia lasting for.30 s on ambulatory cardiacmonitoring. All patients
with recurrences were offered re-do procedures. The use of subsequent
anti-arrhythmics following ablation was determined on clinical needs.
The total number of re-do ablations and subsequent outcomes over
3 years are presented.
Magnetic resonance image acquisition
The CMR sequences used in a 1.5 Tesla Philips Achieva MR system (Philips
Healthcare) to acquire the images have been described previously.5
In brief, T2-weighted images were acquired via a multi-slice turbo spin
echo technique with a double inversion recovery pre-pulse for black-
blood imaging. Late gadolinium enhancement visualization was obtained
via a 3D ECG-triggered, free-breathing inversion recovery turbo field
echo scan, 20 min following contrast agent administration. Images were
acquired at three time points: (1) prior to ablation, (2) within 24 h of
ablation; and (3) 3–6 months following ablation.
Ablation settings
A three-dimensional (3-D) geometry of the LA was created using either
NavX
TM
(St. Jude Medical Inc.) or CARTO XP (Biosense Webster Inc.).
Wide area circumferential ablation was performed in all the patients. In
the robotically navigated group, 30 s energy delivery with power settings
of 25 W on the anterior wall and 20 W on the posterior wall with target
temperatures of 40–428C were delivered. If LA-PV conduction persisted
despite wide area circumferential ablation, additional lesions were deliv-
ered at the sites of earliest activation on the circular mapping catheter
until entry block in all four veins was confirmed by observing the elimin-
ation or dissociation of PV potentials. For standard ablation, power was
30 W on the anterior wall and 25 W on the posterior wall, limited to
up to at 60 s energy delivery.
Image processing and analysis
T2W and LGE signal circumferential quantification were performed by
reconstructing all CMR scans into individual left atrial shells using a semi-
automated 3-D visualization method.9 Areas of LGE or high T2W signal
intensity were defined as being more than three standard deviations
above the mean signal intensity of the simultaneously imaged ventricular
myocardium as previously valated.9,14 The LA surface was colour coded
according to the maximum-intensity projection values, ranging from
green (minimum) to red (maximum).
For each PV pair, T2W and LGE were quantified as occupying a per-
centage of the antral circumference. The % circumferential LGE,
T2-weighted signal and combination of LGE and T2 (LGE+T2) encircling
What’s new?
† This is the first cardiac magnetic resonance (CMR) study per-
formed to prospectively compare the effect of robotic and
standard catheter ablation by late gadolinium enhancement
and evaluate the findings in relation to 6 month and 3 year clin-
ical outcome.
† Robotic-assisted ablation results in greater percentages of
permanent pulmonary vein (PV) encirclement quantified on
CMR, suggesting better catheter contact and stability.
† A significantly less LGE signal regression from acute to late
scan in the robotic recurrences group suggests that acute
energy delivery with this approach produces more durable
lesions.
† A significantly lower number of re-do procedures was
observed in the robotic group over the mean 3 years clinical
follow-up period.
† These data represent the first CMR evidence in man that
robotic-assisted ablations create more efficacious ablation
lesions than a standard manual approach.
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the PVs were quantified. All 3D MR reconstructions were analysed twice
independently by two experienced readers, blinded to clinical outcome
and to the timing of the scan following catheter ablation. A high degree of
inter-observer agreement was seen on a Bland Altman test with a
maximum observed difference of 10% . The mean+ SD inter-observer
error for LGE, T2W, and LGE&T2 was 1.5+2.5%, 1.5+3.5%, and
1.0+2.2% which was acceptable for the purposes of data analysis.
Statistical analysis
Summaries for continuous variables are expressed as mean+ SD.
Follow-up times are reported as median and interquartile range (25th,
75th percentile). Categorical variables were compared among recur-
rences and non-recurrences groups using ax2 test. The % circumferential
encirclement by LGE, T2, and LGE&T2 groups were compared with test
for differences between group means. Statistical analyses were per-
formed using Stata (StataCorp 2011) and Matlab (The Mathworks,
2012b). Analysis of variance was used to compare robotic-assisted
outcome with standard group results. A P value of , 0.05 was consid-
ered statistically significant. Event-free survival curves were estimated
by the Kaplan–Meier product-limit method.
Results
Patient and procedural data
Table 1 outlines the clinical characteristics of the study population in
both groups. Successful PV isolation was achieved in all patients
without a significant difference in RF energy delivered between
groups. At 6 month follow-up, 12 patients (60%) in the robotic
group vs. 11 patients (55%) in the standard group were arrhythmia
free. Median time to recurrence was 78 days (32–146 days) for the
robotic group vs. 96 days (68–167 days) in the standard group. At
median 3-year follow-up (2.2–3.5 years) (Figure 1), 16 patients
(80%) in the robotic group vs. 15 patients (75%) in the standard
group achieved freedom from arrhythmia following 26 vs. 38 proce-
dures (P ¼ 0.0008). Patients in the robotically assisted group experi-
enced an average of 1.3 in comparison to 1.9 procedures per patient
in the standard group. Seven patients with recurrences underwent
one re-do procedure in the robotically assisted group. In contrast,
patients in the standard group undergoing two procedures were
13, undergoing three procedureswere 4, and undergoing four proce-
dures one. Median time interval between index and first re-do pro-
cedure was 30 (21–41) weeks in the robotic group vs. 55 (43–88)
weeks in the standard (P ¼ 0.3). One patient in each group received
a pacemaker (Figure 1). The maximum cumulative number of
arrhythmia-free patients is achieved faster in the robotically assisted
group (Figure 2A).
With regard to anti-arrhythmic use at the time of the procedure,
10 patients in the standard group were on two agents and 10 were
on a single agent. Following catheter ablation, at mean 3 years follow-
up, 13 patients were on no anti-arrhythmic drugs (AAD’s), 2 were on
one agent, and five patients were on two AAD’s (Figure 2B). Con-
versely in the robotic group, 13 patients were on one agent and 7
patients on two agents pre-procedure. Following catheter ablation
at a mean 3 years follow-up, only six patients were on a single AAD
(Figure 2B).
Procedural complications following the index procedure included
two femoral venous haematomas, resolved with conservative man-
agement and one pseudo-aneurysm not requiring surgical interven-
tion. No stroke, tamponade, or oesophageal fistula occurred in this
study and no PV stenosis was detected on follow-up magnetic reson-
ance imaging.
Cardiac magnetic resonance evaluation
within 24 h post catheter ablation
(acute scans) and 3–6 months post
catheter ablation (follow-up scans)
Baseline circumferential burdens of LGE and T2-weighted signal
prior to any ablation were similar in both groups and did not
occupy more than 5% of the PV circumference. Post-ablation acute
imaging was performed between 18 and 24 h following catheter
ablation. Figure 3 demonstrates the typical T2-weighted (Figure 3A)
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Table 1 Baseline characteristics
Total population (N 5 40) Robotic navigation (N 5 20) Manual catheter ablation (N 5 20) P value
Male, n (%) 28 (70) 15 (75) 13 (65) 0.53
Age (years) 54+13.8 54+14.3 55+11.2 0.86
AF duration (months) 30+11.2 32+9.1 30+12.6 0.78
LA size (cm) 3.4+3.5 3.4+0.3 3.5+0.2 0.92
LVEF, % 56+8 58+6 56+8 0.86
Hypertension 11 7 4 .0.10
Diabetes 1 0 1 .0.10
Coronary artery disease 1 1 0 .0.10
Thyroid 2 2 0 .0.10
Smoking 6 4 2 .0.10
Fluoroscopy dose (Gycm2) 1227+667 1291+607 1141+755 0.53
Procedure time (min) 210+26.1 220+21.4 199+27.7 0.06
Number of applications 134+42 141+33 126+58 0.63
Energy delivered (Joules) 84201+28855 88391+28519 80011+28338 0.46
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1st procedure, n = 20
Robotic-assisted
Declined redo
procedure n = 1
Moved out of
region n = 1
Declined redo
procedure n = 1
Pacemaker
n = 1
2nd procedure 2nd procedure
No recurrences
n = 11
No recurrences
n = 4
Recurrences
> 6 months n = 1
No recurrences
n = 1
AAD
n = 1
No
AAD
n = 10
AAD
n = 0
No
AAD
n = 1
AAD
n = 1
No
AAD
n = 3
AAD
n = 1
AAD
n = 1
Recurrences
n = 0
Recurrences
n = 2
AAD
n = 1
AAD
n = 1
Recurrences
< 6 months n = 8
1st procedure, N = 20
Standard
Declined redo
procedure n = 2
Declined redo
procedure n = 1
Pacemaker
n = 1
2nd procedure 2nd procedure
No recurrences n = 7 Recurrences
> 6 months n = 4
No recurrences
n = 3
AAD
n = 0
No
AAD
n = 7
AAD
n = 0
No
AAD
n = 1
No
AAD
n = 3
No
AAD
n = 2
AAD
n = 1
AAD
n = 1
AAD
n = 0
No
AAD
n = 0
AAD
n = 1
AAD
n = 2
Recurrences
n = 1
No recurrences
n = 2
3rd procedure
n = 4
4th procedure
Recurrences
n = 1
Recurrences
n = 0
No Recurrences
n = 2
No Recurrences
n = 1
Recurrences
n = 7
AAD
n = 1
AAD
n = 1
Recurrences
< 6 months n = 9
Figure1 Flowchartoutliningnumberof timesprocedureperformed,outcome ateachstageand theuseof anti-arrhythmicdrugs. Both groupshad
20patients eachundergoing first ablation procedure. In the robotic group, sevenpatients underwenta second procedurewhile threepatients did not
undergo repeat procedures and one patient required a pacemaker. In the standard group, 13 patients underwent a second procedure, four patients a
third procedure, and one patient undergoing a fourth procedure. Three patients declined further procedures and one patient underwent a pace-
maker implantation.
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and LGE (Figure 3B) appearances in two patients before and after
catheter ablation. The left atrial burdens of LGE and the T2-weighted
signal were significantly increased following both catheter ablation
approaches in comparison with pre-ablation. In general, the LGE
signal was concentrated in the PV antral region while the T2W
signal was more widely distributed in the atrium, remote from the
sites of ablation. Combined analyses of the LGE and T2W signals
using reconstructed shells co-displaying both signal types revealed
areas of T2W enhancement overlapping and inter-digitating with
the areas of high LGE signal intensity (Figure 4). Hence the total com-
bined LGE and T2W percentage PV encirclement on the combined
overlay shells was 100% or less.
On the early scans, mean circumferential extent obtained by a com-
bination of LGE&T2 signal overlay was 94+6% in the robotic group
vs. 88%+10% (P ¼ 0.03) in the standard group. Mean LGE encircle-
ment was 72%+8% in the robotically assisted group vs. 60%+17%
(P ¼ 0.002) in the standard group. T2W signals, on the other hand,
were relatively similar in both groups: 80%+12% and 76%+15%
(P ¼ 0.45) for robotically assisted vs. Standard, respectively.
On the follow-up scans the T2W signal had largely resolved
(Figure 5A), while a decline in the extent of the LGE signal was seen
in both groups. In the robotic group, the mean circumferential
extent obtainedby the LGE signal alonewas56+11% in comparison
to 45+20% (P ¼ 0.04) in the standard group. Overall, a higher mean
percentageencirclement was consistently noted in the robotic group
with an average 10% higher mean margin of encirclement observed
on the chronic scans by LGE.
Correlation between clinical outcome and
late gadolinium enhancement assessment
In both robotic and standard groups, acute and follow-up scan
data were analysed into two groups according to the respective clin-
ical outcome—those with and without arrhythmia recurrences
(Figure 5B).
In the robotic group, mean LGE percentage encirclements
observed between no recurrences and recurrences were, 75+8%
vs. 66+ 7% (P ¼ 0.01) on the acute scans and 64+8% vs. 43+
5%, (P, 0.0001) on the follow-up scans.
In the standard group, the corresponding LGE encirclement
are 70+9% vs. 45+ 13% (no recurrences vs. recurrences, P ¼
0.0001) on acute imaging and 60+ 8% vs. 30+ 14% (no recurrences
vs. recurrences, P, 0.0001) on follow-up imaging.
At the 6-month time point, more of the percentage encirclement
observed around the PVs in the acute scans persisted through to the
follow-up scans in the overall arrhythmia-free patient group (robotic
vs. standard: acute scans 275+ 8% vs. 70+ 9%, P ¼ 0.14 and
follow-up scans 64+ 8% vs. 60+8%, P ¼ 0.45). In the recurrences
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Figure2 (A) Cumulative numberof arrhythmia free patients over a 3 years mean follow-up period. (B ) Anti-arrhythmic use pre- and post-ablation
in both groups at follow-up.
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group, LGE was higher in the robotic group (acute scans 266+ 7%
vs. 45+13%, P ¼ 0.007 and follow-up scans 43+5% vs. 30+14%,
P ¼ 0.001). A higher co-efficient of variation is observed in the stand-
ard recurrences group 0.28 and 0.46 in comparison to the 0.1 and
0.11 in the robotic recurrences group (Table 2).
A comparison of energy delivered, follow-up CMR LGE and
6 months clinical outcome between the two groups is presented in
Figure 6. In the standard group, there is no correlation between
energy delivery and observed LGE on the follow-up scans. Even at
high-energy delivery, low LGE values are observed. Conversely, the
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Figure3 Serial T2W (A) and LGE (B)CMR scans performed on a single patient following robotic and standardnavigated catheterablationat3 time
points. In the T2W series, both groups demonstrate an increase in signal intensity and atrial wall thickness following ablation which resolves on the
late follow-up scans. In the LGE series (B), baseline images in the first column show no significant DE signal (tissue injury/necrosis) compared with
acute post-ablation images in the second column. The late scans in the third column shows that areas of LGE signal become less diffuse and more
defined with sharper borders in comparison to the acute scans.
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points on the robotic scatter plot are less spread and more close to-
gether. The % PV encirclement by LGE values are generally above
40% in robotically assisted procedures.
Discussion
This is the first CMR study performed to prospectively compare the
effect of robotic and standard catheter ablation by LGE and evaluate
the findings in relation to 6 months and 3 years clinical outcome. The
main findings of this study are (1) robotic-assisted ablation results in
greater percentages of permanent PV encirclement quantified on
CMR; (2) there was significantly less LGE signal regression from
acute to late scan in the robotic recurrences group, suggesting that
acute energy delivery with this approach produces more durable
lesions; (3)at a set range of energy delivery, more robotic points
with higher LGE was observed in the scatter plot, suggesting
increased catheter contact and stability; (4) and significantly lower
number of re-do procedures were observed over the mean 3 years
clinical follow-up period. These data represent the first CMR evi-
dence in man that robotic-assisted ablations create more efficacious
ablation lesions than a standard manual approach.
Recently, improvedelectrogramsignal attenuation during catheter
ablation has been demonstrated in robotic navigated proce-
dures.15,16 Both catheter stability and constant energy delivery
were deemed key in achieving bipolar electrogram attenuation.
This CMR study demonstrating increased LGE in robotic-assisted
procedures provides a mechanistic explanation suggesting greater
tissue injury as a result of greater catheter–tissue contact, leading
to better electrogramattenuation.An approximate 50% electrogram
attenuation achieved within 30 s of ablation in the standard group in
comparison to 15 s in the robotic group was reported.
The findings of the Efficas studies strongly suggest that initial cath-
eter contact force at the onset of RF delivery is a critical determinant
of lesion quality, as assessed by the force time integral and lesion con-
tinuity index, with clinical outcome being predicted by the poorest
quality lesion delivery and greater catheter instability.17 This study
supports this hypothesis by demonstrating a 10% higher percentage
encirclement observed on the robotic navigation system (RNS) late
scans in comparison with the standard group. A lower regression of
the LGE signal between the acute and late scans in the robotic recur-
rences group suggests the creation of a more durable lesion. The nar-
rower range in % encirclements in the robotic group infers less
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Figure4 Example of a series of 3-D LA reconstructed shells (at 3 time points) in two patients to compare robotic (A) vs. standardcatheter ablation
(B). Blue represents areas of T2 signal while red represents LGE. More ‘islands’ of red are seen in the robotic assisted LA shell implying greater tissue
injury achieved. The first row represents the raw data transferred onto the atrial shell, each for T2 and LGE (Row A). The second row represents the
semi-automated quantification of T2 and LGE signals (Row B). The third row demonstrates the combination of T2 and LGE from the second row
onto a single atrial shell (Row C).
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variability in lesion delivery, suggesting better tissue contact. While this
did not translate into improved clinical outcome after a single proced-
ure, a reduction in the number of re-do procedures and anti-
arrhythmic agent use is observed. It is important to note that acute
LGE imaging is less likely to represent true scar as there is an overlap
of injured tissue as well as inflammation. Late gadoliniumenhancement
quantified on late scans represents a better marker for true scar as the
inflammation settles and injured tissue become more defined.
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Figure 5 (A) Scatter-boxplot shows a comparison of pre, acute and late T2, LGE and combined T2&LGE for both robotic (green) and standard
(brown) ablation. Each individual scatter plot represents the raw data for that specific group. The dots within each group have been dispersed hori-
zontally to optimize visualization and clarity. The boxplots on the other hand represent median (red line), 95% confidence intervals (pink box) and 1
standard deviation (green/brown box). An overall higher enhancement is seen post-procedure in the robotic group compared with the standard
group. The higher percentage encirclements by LGE assessment in the robotic group continued to remain significantly more in the follow-up
scans. The overall lower standard deviation in the robotic group suggests better consistency in creating tissue injury. This is most likely a function
of catheter stability resulting in better tissue contact. (B) Overall, a higher percentage encirclement is noted in the robotic group with statistical
significance achieved in the recurrences cohort. This may have potential consequences for re-do ablation procedures.
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Table 2 Coefficient of variation between robotically assisted and standard ablation in acute and follow-up scans for no
recurrences vs. recurrences
Acute Follow up
Robotically assisted Standard Robotically assisted Standard
No recurrences 0.10 0.12 0.12 0.13
Recurrences 0.10 0.28 0.11 0.46
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The association between energy delivered and scar formation ana-
lysed on the 6-month LGE CMRscanswas examined. At a set range of
energy delivery, more points with higher DE were observed on the
robotic scatter plot. We hypothesise that this is attributable to
better catheter control and stability conferred by the RNS. The
better consistency and higher reproducibility inferred from both
the smaller standard deviation and the more closely placed points
on the scatter plot imply a relatively a higher precision in lesion deliv-
ery in the robotic group in comparison to the standard.
The 3years clinical outcomefindings suggest that the overall higher
LGE observed in the robotically assisted group translates into a sig-
nificantly less number of re-do procedures. These findings corrobor-
ate a similarmid-term studyoutcome previously reported.18 Durable
tissue injury created by both better catheter–tissue contact and
catheter stability reduces the need for multiple re-do ablation proce-
dures. The implications here on overall patient wellbeing and health
cost-efficiency warrant a further larger study. The overall greater re-
duction in the number of anti-arrhythmics pre-and post-ablation in
the robotically assisted group suggests a better modification of the
atrial tissue, resulting in better symptom control even in patients
with recurrences.
Study limitations
This is a small mechanistic study aimed at assessing the correlations
between catheter stability, tissue injury, and clinical outcome. The
true clinical impact of RNS-assisted catheter ablation on mid- to long-
term clinical outcome would require a larger randomized study for
validationof thefindings.However, thiswasnot theprimaryobjective
of this hypothesis-driven CMR assessment of atrial injury. Failure to
detect asymptomatic recurrences of AF means that the incidence
of asymptomatic AF is likely to be underreported in this study.
The correlation between contact-force and LGE lesion character-
istics is not assessed here. A separate study evaluating this is planned.
Conclusion
The increased LGE seen on CMR scans following robotic-assisted
catheter ablation suggests a greater extent of tissue injury around
the PV antrum in comparison with the standard approach. This is
likely to be a function of better catheter stability and more effective
lesion delivery.
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Occasional dropped ventricular pacing in a patient with no underlying
rhythm and an Advisaw dual-chamber pacemaker
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An86-year-oldwhitemalebrought totheemergency
room for weakness and lethargy was found to have
third degree AV block with a left bundle branch
escape rhythm (Figure 1A). An Advisa MRIw (Medtro-
nic) dual-chamber pacemaker was implanted. Tel-
emetry tracings revealed asymptomatic episodes
of isolated P waves without pacing spikes or
paced QRS complexes (Figure 1B). Decreasing
the sensitivity to 11.3 mV in the RV channel elimi-
nated this phenomenon.
Medtronic engineers provided the following
details:
† An occasional ‘droppedVP’ is specific to DDDR
and DDD modes during atrial tracking (AS–VP)
and may occur intermittently on an hour and
30 s schedule.
† A false ventricular sense may occur due to re-
sidual electrical disturbance on the ventricular
sense amplifier and may be created by turning on/off the diagnostic EGM amplifiers during reference EGM collection. The scheduled
reference EGM collection is synchronized to sensing and pacing events so that the device’s sense amplifiers are blanked. However,
there is no ventricular blanking following an AS event, which makes this phenomenon possible. The collection of reference EGM is non-
programmable and is always active in the device.
† Decreasing the ventricular sensitivity from 0.9 to 1.2 mV or higher may eliminate this phenomenon. Medtronic reliability engineers
estimated the worldwide rate of occurrence at ,0.05% worldwide, but this may be underreported.
The full-length version of this report can be viewed at: http://www.escardio.org/communities/EHRA/publications/ep-case-reports/
Documents/occasional-dropped-ventricular.pdf.
Published by Oxford University Press on behalf of the European Society of Cardiology 2015. This work is written by (a) US Government employee(s) and is in the public
domain in the US.
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